Novo Nordisk’s stock tumbles as drugmaker lays out case for declining sales in 2026

8 hours ago 3
ARTICLE AD BOX
The maker of Ozempic and Wegovy blamed pricing pressures and competition for its downbeat outlook.
Read Entire Article
  1. Homepage
  2. Finance
  3. Novo Nordisk’s stock tumbles as drugmaker lays out case for declining sales in 2026

Related

Stocks fall as S&P 500 dragged down by tech. Is the selling over?

Stocks fall as S&P 500 dragged down by tech. Is the selling ...

3 hours ago 2
Super Micro logs record revenue from AI demand, and the stock surges

Super Micro logs record revenue from AI demand, and the stoc...

4 hours ago 2
Elon Musk’s plans for SpaceX data centers in orbit could cost $5 trillion a year, analysts say

Elon Musk’s plans for SpaceX data centers in orbit could cos...

5 hours ago 2

Trending

1. derrick white
2. baylor scheierman
3. brandin podziemski
4. bernie goetz
5. san diego fc vs pumas unam
6. micah parsons
7. is steph curry playing tonight
8. brian angelichio
9. jalen johnson
10. katie miller

Popular

Can Pidcock win big & why did it end at Ineos?

Can Pidcock win big & why did it end at Ineos?

11 months ago 530
‘I didn’t want to spend time with my children. I was just going through the motions’: the pain of parental burnout

‘I didn’t want to spend time with my children. I was just go...

11 months ago 494
‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided Beauty Standards Through Asian Eyes

‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided...

10 months ago 467
Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

11 months ago 410
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

11 months ago 363
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2026. All rights are reserved